Expanding antiviral therapy in chronic hepatitis B: Evidence, uncertainties, and clinical considerations

Yingying Yuan, Wei Li, Yingfang Yuan, Kai Zuo

Open source

DOI
10.1016/j.jfma.2026.10.016
Published
2026-10
Container
Journal of the Formosan Medical Association
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jfma.2026.10.016,
  title = {Expanding antiviral therapy in chronic hepatitis B: Evidence, uncertainties, and clinical considerations},
  author = {Yingying Yuan and Wei Li and Yingfang Yuan and Kai Zuo},
  year = {2026},
  journal = {Journal of the Formosan Medical Association},
  doi = {10.1016/j.jfma.2026.10.016},
  url = {https://doi.org/10.1016/j.jfma.2026.10.016}
}

RIS

TY  - JOUR
TI  - Expanding antiviral therapy in chronic hepatitis B: Evidence, uncertainties, and clinical considerations
AU  - Yingying Yuan
AU  - Wei Li
AU  - Yingfang Yuan
AU  - Kai Zuo
PY  - 2026
JO  - Journal of the Formosan Medical Association
DO  - 10.1016/j.jfma.2026.10.016
UR  - https://doi.org/10.1016/j.jfma.2026.10.016
ER  - 

APA

Yuan, Y., Li, W., Yuan, Y., & Zuo, K. (2026). Expanding antiviral therapy in chronic hepatitis B: Evidence, uncertainties, and clinical considerations. Journal of the Formosan Medical Association. https://doi.org/10.1016/j.jfma.2026.10.016

Source records